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Abstract
Background: The relationship between chronic periodontitis (CP) and increased risk for cardiovas-
cular disease (CVD) is known but quantitative assessments and mechanisms are not fully understood. 
The aim of this study was to assess the relationship between past myocardial infarction (MI) and the 
severity of CP, and the level of serum antibody titer against Porphyromonas gingivalis gingipains. 
Methods: The study sample consisted of 97 patients after MI and 113 high risk controls with no history 
of coronary heart disease (CHD) matched with age, sex and place of residence (urban vs. rural). Data 
on the history of CHD and presence of risk factors were collected. Periodontal status was assessed using 
the Community Periodontal Index (CPI), clinical attachment loss (CAL), bleeding on probing (BOP) 
and pocket depth. 
Results: After adjustment for potential confounders patients with BOP = 20–50% and BOP > 50% 
had more than four times higher odds of past MI (OR = 4.56; 95% CI 2.03–10.27). Patients with CPI 
code = 4 had a three times higher odds of past MI (OR = 3.18, 95% CI 1.01–10.06). CAL ≥ 6 was 
related to higher odds of past MI (OR = 1.28, 95% CI 1.11–1.49). Patients with moderate antibody titer 
levels had an almost 3 times higher odds of past MI (OR = 2.82, 95% CI 1.02–7.84).
Conclusions: There was an association between CP and past MI, which was independent of classical 
CVD risk factors and confirmed by an association between past MI and immunological reaction against 
P. gingivalis gingipains. (Cardiol J 2018; 25, 3: 386–392)
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Introduction
An increasing number of studies have shown 
a relationship between chronic periodontitis (CP) 
and increased risk of cardiovascular disease (CVD) 
even after controlling for possible confounders 
[1, 2]. CP has been postulated to be a CVD risk factor, 
which is independent of well-known risk factors, 
such as smoking, hypertension, obesity, diabetes 
and hypercholesterolemia [3, 4]. CP is an inflam-
matory disease of tooth supporting tissues and is 
commonly prevalent among the middle-aged and 
the elderly in the general population. The preva-
lence of CP in the general European population is 
estimated to be over 50%, and the percentage of 
patients with severe forms of CP is over 20% [5]. 
Its prevalence increases with age. According to 
a recent nationwide Polish study, almost 20% of 
the population from large Polish cities aged 35–44 
years and almost 32% aged 65–74 years had severe 
CP [6].
The most pathogenic and etiologic bacteria 
for CP are: Porphyromonas gingivalis, Bacteroides 
forsythus, Treponema denticola, Eikenella corrodens, 
Campylobacter rectus, Prevotella intermedia, and 
Fusobacterium nucleatum [7]. P. gingivalis is the 
most frequent bacteria and is identified in 85% of 
sites of CP [8]. P. gingivalis has a number of poten-
tial virulence factors, such as cysteine proteinases 
— gingipains (GPs), lipopolysaccharide, capsules, 
and fimbriae [9]. GPs contribute to 85% of the 
total proteolytic activity of P. gingivalis [10] and 
are crucial in inducing CP since they have multi-
directional adverse impacts on the immune system. 
The patomechanism of the relation between CP and 
coronary heart disease (CHD) is still unclear, but 
in general two mechanisms have been postulated. 
The first is the general inflammatory host response 
in CP, which is supported by the findings of elevated 
inflammatory markers (C-reactive protein) in CP 
patients and their decrease after successful treat-
ment of periodontitis [11]. Furthermore, it has 
been found that P. gingivalis may increase overall 
inflammatory response through its virulence fac-
tor, especially GPs [12, 13]. The second postulated 
mechanism involves direct invasion of arteries 
and endothelial cells by periodontal pathogens, 
especially P. gingivalis. The latter is supported by 
findings that endothelial dysfunction, which plays 
a key role in the development of arteriosclerotic 
plaques, was associated with CP [14]. Further-
more, antibodies against P. gingivalis have been 
found in human arteriosclerotic plaques [15] and 
experimentally induced P. gingivalis bacteremia 
accelerated formation of arteriosclerotic plaques 
in pigs [16]. In addition, defects in endothelial cells 
and arteriosclerotic plaques that appear as the 
effect of CP may be a background for myocardial 
infarction (MI) [15].
In most studies showing an association be-
tween CP and CHD, periodontal status was based 
on clinical examination or self-reporting. Such 
methods do not allow for the assessment of sys-
tematic immunological response to CP. The level of 
antibodies against periodontopathogenic bacteria, 
especially their major virulence factors as a better 
indicator of the CP [17] could be a more accurate 
measure of the link between CP and systemic dis-
eases. Therefore the aim of this study was to assess 
the association between past MI and the clinical 
parameters of CP in the context of the level of se-
rum antibody titer against P. gingivalis gingipains. 
Methods
Study design
A frequency-matched case-control study was 
performed to identify factors which are associated 
with past MI that are related to the periodontium 
health status. The potential characteristics ex-
plored were: pocket depth (PD), clinical attachment 
loss (CAL), bleeding on probing (BOP), community 
periodontal index (CPI), and the titer of antibody 
(AT) directed against gingipains. The study group 
consisted of 220 patients, including 97 cases and 
113 controls. 
For a type I error of 5% and power of 80%, 98 
cases were sufficient to detect an odds ratio > 2.2 
for factors with a prevalence of 35% in the general 
population [18].
Studied groups
Patients after MI were recruited from five 
cardiology departments, serving the city of Krakow 
and the surrounding rural area. Patients aged ≥ 18 
years and ≤ 80 years, with definite clinical diagno-
sis of MI, were identified from medical records, 
excluding those who died during their in-hospital 
stay and were asked to undergo dental examination. 
Controls were persons with no diagnosis of 
MI or CHD, who were selected randomly from 
three general practices: two in Krakow and one 
outside of Krakow. Inclusion criteria were: high 
CVD risk identified by attempted treatment for 
hypertension, hypercholesterolemia or diabetes 
mellitus. Information on treatment was collected 
from medical records using a standardized data 
collection form. Then, controls were matched ac-
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cording to their age (5-year groups), sex and place 
of residence (rural vs. urban) and were asked to 
undergo dental examination. However, of the 113 
controls, 91 (80.5%) were comprised of men and 
22 (19.5%) women, i.e. 5 women less than in the 
previous MI group. Those 5 women were excluded 
because they had less than 6 teeth.
In both groups, the exclusion criteria were: 
use of antibiotics during the 2 weeks prior to the 
examination, and immunosuppressive therapy or 
chemotherapy.
Data collection
Data on demographic characteristics, personal 
history of CHD, smoking status, blood pressure, 
fasting glucose, plasma lipids and prescribed medi-
cations were obtained using a standardized data 
collection form. Patient height and weight were 
measured in a standing position without shoes 
and heavy outer garments using standard scales 
with a vertical ruler. Blood pressure was measured 
twice, on the right arm in a sitting position after 
at least 5 min of rest. For plasma lipid and glucose 
measurements, a fasting venous blood sample was 
taken between 7:30 AM and 8:30 AM. Biochemical 
analyses were carried out no later than 4 h after 
blood collection. All analyses were performed at 
one central laboratory. 
Dental examination
Periodontal condition was assessed in partici-
pants with at least 6 teeth. Dental clinical exami-
nation was carried out according to World Health 
Organization recommendations [19]. Participants 
were examined by one qualified dentist. Standard 
intraoral examination was performed starting 
from the first to the fourth quadrant. Pocket depth 
was measured on 6 sites around each tooth using 
a PCPUNC15-type periodontal Hu-Friedy probe. 
BOP was evaluated according to Ainamo and Bay 
[20]. For each patient, the percentage of teeth 
with bleeding after gentle probing was calculated. 
Results were interpreted as follows: BOP > 50% 
severe, advanced CP, BOP = 20–50% moderate CP, 
BOP = 19–10% mild CD, BOP < 10% no CP. CAL 
was defined as the distance between the pocket 
bottom and the cement-enamel junction. The CPI 
was used to record periodontal status [21]. CPI 
ranged from 0 to 4, representing healthy (CPI 0), 
bleeding on probing (CPI 1), calculus or conditions 
for dental plaque retention (CPI 2), 4–5 mm pocket 
depth (CPI 3) and ≥ 6 mm pocket depth (CPI 4). 
Participants were classed into CPI groups accord-
ing to the worst measurement in any quadrant.
Serum samples for antibody determination
Serum samples for antibody determination 
were stored at −80°C immediately after centrifu-
gation. Immunoglobulin G antibody titers against 
P. gingivalis GPs were determined using the en-
zyme-linked immunosorbent assay (ELISA), in all 
samples using the method described by Zdzalik et 
al. [22]. Antibody titers are given in ELISA units.
Definition of CVD risk factors
Participants were considered smokers, if they 
declared they had smoked at least one cigarette 
during 1 month prior to the interview or had 
≥ 10 ppm carbon monoxide in their exhaled air. 
The concentration of carbon monoxide in exhaled 
air was measured using Smokerlyzer Micro+ 
(Bedfont Scientific Ltd, England). Hypertension 
was defined as blood pressure ≥ 140/90 mmHg or 
antihypertensive drugs taken by a patient. Hyper-
cholesterolemia was defined as total cholesterol 
≥ 5.0 mmol/L or low density lipoprotein ≥ 3.0 mmol/L 
or lipid lowering drugs taken by a patient. Diabetes 
mellitus was defined as fasting glucose ≥ 7 mmol/L 
or self-reported history. Obesity was defined as 
body mass index ≥ 30 kg/m2.
Statistical analysis
All analyses were performed together for males 
and females. Cases and controls were compared for 
demographic characteristics, health status variables 
and oral health indices using t-Student, Mann-
-Whitney or c2 tests as appropriate. Unconditional 
logistic regression was used to assess the relation 
between periodontal indices, level of antibody 
titer and past MI. Three models were examined: 
a univariate model (model A), and two multivariate 
models in which the matching variables were forced 
into model. Model B was adjusted for age, gender 
and education. The final model (model C) included 
additional covariates: smoking, diabetes, hyperten-
sion, hypercholesterolemia, and body mass index. 
Antibody titer was included in the logistic regres-
sion as a categorical variable. Based on a frequency 
distribution of all subjects, antibody titer values 
were divided into three categories and then com-
pared between cases and controls. The reference 
category included the lowest 10 percent of values 
(AT < 900), titers above 900 to the median value 
( = 8,100) formed the second category, values above 
the median were included in a third category.
Sensitivity analysis that restricted cases and 
controls to 1:1 matching was also performed. The 
frequency-matched case-control analysis included 
92 pairs of observations. Five cases were excluded 
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due to lack of appropriately matched controls within 
the gender.
Results are presented as odds ratios (OR) with 
95% confidence intervals (95% CI). Analyses were 
performed using SPSS Software (IBM, Armonk, 
NY, USA). Statistical significance was accepted at 
the level of a = 0.05.
Ethics
All participants were informed about the study 
protocol and gave their informed consent. The 
study was approved by the Bioethics Committee 
of the Jagiellonian University.
Results
There were no significant differences in mean 
age and distribution by sex between the stud-
ied groups. Patients after MI were slightly less 
educated than controls. However, the prevalence 
of CVD risk factors, i.e. smoking, hypertension, 
hyperlipidemia, obesity, and diabetes, were similar 
(Table 1).
Patients after MI had a lower mean number of 
teeth (15 vs. 18). On average, they also had their 
teeth affected by periodontal disease more fre-
quently than the controls. Cases were more likely 
than the controls to have some periodontal pocket-
ing of 6 mm or more (29.9% vs. 17.7%, respectively) 
and had a significantly higher median value of CAL 
(7 mm compared to 6 mm for controls, p < 0.001). 
They were also more likely to have a higher percent-
age of bleeding teeth and to have some teeth with 
calculus deposits or conditions for dental plaque 
retention. Cases had a higher percentage of partici-
pants with CPI stage 4 and BOP > 50%. However, 
differences in antibody titer against P. gingivalis 
gingipains between the cases and the control group 
were not observed when compared as a quantitative 
variable or a categorical variable (Table 2).
Table 3 shows clear and consistent ORs of 
past MI for various periodontal health indicators. 
After adjustment for age, sex, years of edu-
cation, smoking, hypertension, hypercholester-
olemia, body mass index, diabetes mellitus, and 
number of teeth, those patients with BOP 20–50% 
and BOP ≥ 50% had a more than 4 times higher 
odds of past MI. Patients with CPI 4 code had 
a 3 more times higher odds of past MI and those 
with CAL ≥ 6 mm had a 1.28 odds of past MI. As-
sociation between PD ≥ 6 mm and past MI was at-
tenuated after adjustment for possible confounders. 
A clear relationship between antibody titer and the 
odds of past MI was not apparent in the univariate 
model. When some potential confounding factors 
were entered into regression models, those pa-
tients from antibody titer group 2,700–8,100 had 
an almost 3 times higher odds of past MI.
In a separate model (not shown in the tables), 
the sample was limited to 92 cases and their 92 
matched controls. The relations between past MI, 
CP and antibody titer in the unconditional and 
conditional models were similar.
Discussion
These results indicate that impaired periodon-
tal health is associated with prevalence of past MI 
which was confirmed also by increased antibody 
titer against P. gingivalis gingipains in patients 
after MI. The relation was independent of classic 
CVD risk factors.
Table 1. General descriptive statistics and cardiovascular disease risk factors in the study groups.
  MI (n = 97) Control group (n = 113) P
Age [years]* 60.5 ± 8.7 60.4 ± 8.7 0.94C
Men 72.2% 80.5% 0.15A
Years of education [years]** 12.0 (10.0–15.0) 13.0 (11.0–17.0) 0.005B
Body mass index [kg/m2]* 29.0 ± 4.7 28.6 ± 4.7 0.61
Arterial hypertension 80.4% 73.0% 0.21
Diabetes 23.4% 24.3% 0.88
Hyperlipidemia 71.3% 79.7% 0.16
Obesity 36.1% 31.8% 0.52
Smoking 17.7% 17.9% 0.98
*Mean ± standard deviation; **Median (upper-lower quartile); Ac2 test; BMann-Whitney U test; CStudent T test; MI — myocardial infarction; 
n — number of participants
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Table 2. Descriptive statistics for oral and periodontal health in the study groups.
  MI (n = 97) Control group (n = 113) P
Number of teeth 15 ± 6 18 ± 7 0.0006A
Pocket depth [mm] 5 (4–6) 5 (4–5) 0.12
Pocket depth ≥ 6 mm 29.9% 17.7% 0.04
CAL [mm] 7 (6–9) 6 (5–7) < 0.0001
BOP less than 20% teeth 29.47% 69.03% < 0.001
BOP = 20–50% teeth 35.79% 15.93%
BOP above 50% teeth 34.74% 15.04%
CPI 0 0% 8.9% < 0.001
CPI 1 18.6% 8.9%
CPI 2 33% 23.8%
CPI 3 21.7% 52.2%
CPI 4 26.8% 6.2%
Antibody titer [median, Q1–Q3] 8100 (2700–24300) 8100 (2700–24300) 0.36
Low AT ≤ 900 9.3 14.2 0.13
Moderate AT 2700–8100 52.6 38.9
high AT > 8100 38.1 46.9
AT — antibody titter; BOP — bleeding on probing; CAL — clinical attachment loss; CPI — community periodontal index; MI — myocardial 
infarction; n — number of participants; Q — quartile; AStudent T test
Table 3. Relation between periodontal health parameters, antibody against P. gingivalisgingipains and 
myocardial infarction status.
Model A
OR (95% CI)
Model B
OR (95% CI)
Model C
OR (95% CI)
Pocket depth < 6 mm 1 1 1
Pocket depth ≥ 6 mm 1.98 (1.03–3.81) 1.95 (0.99–3.82) 1.91 (0.95–3.84)
CAL ≥ 6 2.35 (1.19–4.67) 1.31 (0.14–1.51) 1.28 (1.11–1.49)
BOP less than 20% teeth 1 1 1
BOP = 20–50% teeth 5.26 (2.56–10.81) 5.06 (2.42–10.58) 4.34 (2.00–9.44)
BOP above 50% teeth 5.41 (2.60–11.24) 5.02 (2.29–11.01) 4.56 (2.03–10.27)
CPI 0 or 1 1 1 1
CPI 2 1.32 (0.58–3.00) 1.04 (0.43–2.47) 0.96 (0.39–2.40)
CPI 3 0.40 (0.18–0.89) 0.33 (0.14–0.79) 0.27 (0.11–0.68)
CPI 4 4.13 (1.44–11.87) 4.03 (1.34–12.13) 3.18 (1.01–10.06)
Low AT ≤ 900 1 1 1
Moderate AT 2700–8100 2.06 (0.82–5.15) 2.76 (1.05–7.24) 2.82 (1.02–7.84)
High AT > 8100 1.24 (0.49–3.13) 1.48 (0.57–3.87) 1.37 (0.50–3.76)
Model A non adjusted
Model B adjusted for: sex, age and years of education
Model C adjusted for: sex, age, years of education, smoking, hypertension, hypercholesterolemia, body mass index, diabetes mellitus and 
number of teeth
AT — antibody titter; BOP — bleeding on probing; CAL — clinical attachment loss; CI — confidence interval; CPI — community periodontal 
index; n — number of participants; OR — odds ratio
The relationship between CP and MI was first 
reported by Matilla et al. [1] and later confirmed in 
the studies which showed 1.2–2.0 times increased 
odds for MI [23, 24]. In contrast, some studies showed 
negative relationships between periodontal disease 
and CHD. Hujoel et al. [25] and Tuominen at al. [26] 
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reported that CP was not associated with CHD after 
controlling for CVD risk factors. Depending on the 
indicator, in our study we showed increased odds of 
past MI in CP patients by 1.2–5.0 times compared to 
non CP patients. The inconsistencies in the strength 
of the relation may be explained partially at least 
that various indices have been adopted to assess CP. 
However, a unified indicator for CP in population 
studies is not yet defined. Also, definitions of CHD 
varied among the studies. Some studies included 
only patients with history of acute MI, whereas oth-
ers included patients with stable or unstable angina. 
It was decided to include only patients with verified 
definite clinical diagnosis of acute MI. 
The evidence for the relationships between 
CHD and the level of antibody against P. gingivalis 
is inconsistent. In our study we found that high 
antibody titer against P. gingivalis gingipains is 
related to an almost 3 times increased chance of MI. 
This confirms the finding of another other study in 
which males aged 45 to 75 years who were sero-
positive for P. gingivalis had more frequent CHD 
than those who were seronegative for P. gingivalis 
[27]. Alternatively, some cross-sectional studies 
have shown no association between antibodies 
against P. gingivalis and CHD, after adjustment for 
classic CVD risk factors [28, 29].
The present study has several strengths. The 
main one is the use of antibody titer to investigate 
associations between CP and MI. The use of defini-
tion of CP based on clinical parameters, i.e. pocket 
depth, to assess relationships between CP and 
other chronic diseases has been criticized. Clinical 
parameters might not be a good indicator of the ef-
fect of long-lasting influence of bacterial infection. 
Thus, antibody titer seems to be a better marker of 
immunological response for periodontal bacteria. 
Another strength of this study is that cases and 
controls were highly comparable. Patients after 
MI were selected from patients from 5 clinical car-
diology wards serving a defined geographical area 
and the controls were sex, age place of residence 
matched, and constituted of a random sample of 
high risk persons registered in selected primary 
practices serving the same residential area. Re-
striction of the control group to persons at high 
risk allowed us to limit confounding by CVD risk 
factors which was controlled further by adjustment 
for these in the multivariate analyses.
However case-control design which does not 
allow for firm conclusions on causality remains 
the main limitation of the study. Furthermore, the 
study sample had limited statistical power, although 
it appeared to be sufficient to find a strong associa-
tion. Also, the strong relation between BOP and 
past MI might be explained at least partially by 
the use of antiplatelet agents. We were not able 
to adjust for this this effect as nearly all MI par-
ticipants were taking these agents. However, the 
relation between BOP and antiplatelet treatment 
was not confirmed unequivocally [30]. It is also 
possible that patients after MI had been paying less 
attention to oral hygiene as a result of their history 
of serious disease and as in a consequence had 
developed more severe CP than healthy persons. 
Antibody levels for periodontopatic bacteria are 
considered to be stable over time, but it remained 
unclear whether antibody level is an indicator 
of disease history or active infection. The other 
limitation is that the present study assessed only 
antibody for one periodontopathogenic bacteria. It 
is possible that if the presence of antibodies against 
other periodontitis-associated bacterial species 
were included in the analysis the relationships 
could have been stronger.
Conclusions
In conclusion, an association was found between 
chronic periodontal disease and past MI which was 
independent of classical CVD risk factors and con-
firmed by the association between past MI and im-
munological reactions against P. gingivalis gingipains.
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